Spoken Alpha
Harvard Apparatus Regenerative Technology, Inc.
I don't have access to the actual Item 1 — Business section content from Harvard Apparatus Regenerative Technology's 10-K filing. The text you provided contains only forward-looking statements disclaimers and references to other sections, not the business description itself.
Harvard Apparatus Regenerative Technology, Inc is a Consumer Defensive company operating in Packaged Foods with a $46.7M market cap.
Most recent reported earnings: Q2 FY2026 (Jun 29, 2026).
2 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HRGN.
$ curl https://api.spokenalpha.com/v1/companies/HRGNFAQ
Spoken Alpha indexes HRGN's earnings call transcripts at https://spokenalpha.com/companies/HRGN. Each call links to attributed speakers and parsed analyst Q&A.
Harvard Apparatus Regenerative Technology, Inc. (HRGN) held its most recent earnings call on 2022-11-15, covering fiscal Q3 2022.
Harvard Apparatus Regenerative Technology, Inc. (HRGN) operates in the Consumer Defensive sector (Packaged Foods industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-06-29 | $-0.10 | — | — | $414.0K | — | — | EODHD |
| Q1 FY2026 | 2026-05-17 | $-0.09 | — | — | $226.0K | — | — | EODHD |
| Q4 FY2025 | 2026-02-24 | $-0.10 | $0.00 | — | $219.0K | — | — | EODHD |
| Q3 FY2025 | 2025-11-27 | $-0.10 | $0.00 | — | $123.0K | — | — | EODHD |
| Q2 FY2025 | 2025-08-28 | $-0.11 | $0.00 | — | $317.0K | — | — | EODHD |
| Q1 FY2025 | 2025-05-11 | $-0.08 | — | — | $45.0K | — | — | EODHD |
| Q4 FY2024 | 2025-03-30 | $-0.08 | $0.00 | — | $258.0K | — | — | EODHD |
| Q3 FY2024 | 2024-11-10 | $-0.12 | — | — | $59.0K | — | — | EODHD |
| Q2 FY2024 | 2024-08-12 | $-0.18 | — | — | $56.0K | — | — | EODHD |
| Q1 FY2024 | 2024-05-12 | $-0.13 | — | — | $57.0K | — | — | EODHD |
| Q4 FY2023 | 2024-03-27 | $-0.13 | — | — | $63.0K | — | — | EODHD |
| Q3 FY2023 | 2023-11-12 | $-0.12 | — | — | $40.0K | — | — | EODHD |
| Q2 FY2023 | 2023-08-13 | $-0.19 | $0.00 | — | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-11 | $-0.24 | $0.00 | — | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-29 | $-0.13 | $0.00 | — | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-0.10 | $0.00 | — | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $-0.12 | $0.00 | — | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-03-31 | $-0.61 | $0.00 | — | — | — | — | EODHD |
| Q3 FY2021 | 2021-11-14 | $-0.08 | $0.00 | — | — | — | — | EODHD |
| Q2 FY2021 | 2021-08-12 | $-0.61 | $0.00 | — | — | — | — | EODHD |
Source: EODHD. HRGN reported actuals as published; sparse fields render as —.